Nasdaq · Common stock
Yarrow Bioscience (YARW)
$20.00 +$0.73 (+3.79%)
- Day’s range
- $18.99–$20.07
- Volume
- 162,232
YARW price history
YARW closed at $20.00 on Oct. 26, 2026. Over the past year, its daily close ranged from $18.31 on Oct. 16, 2026 to $42.94 on Aug. 11, 2026.
Data table: YARW daily closes, the past year
| Date | Close |
|---|---|
| Oct. 26, 2026 | $20.00 |
| Oct. 23, 2026 | $19.27 |
| Oct. 22, 2026 | $19.60 |
| Oct. 21, 2026 | $20.17 |
| Oct. 20, 2026 | $20.21 |
| Oct. 19, 2026 | $19.98 |
| Oct. 16, 2026 | $18.31 |
| Oct. 15, 2026 | $20.00 |
| Oct. 14, 2026 | $18.90 |
| Oct. 13, 2026 | $18.60 |
| Oct. 12, 2026 | $19.82 |
| Oct. 9, 2026 | $19.71 |
| Oct. 8, 2026 | $19.87 |
| Oct. 7, 2026 | $18.77 |
| Oct. 6, 2026 | $18.73 |
| Oct. 5, 2026 | $20.30 |
| Oct. 2, 2026 | $22.27 |
| Oct. 1, 2026 | $23.60 |
| Sept. 30, 2026 | $22.52 |
| Sept. 29, 2026 | $24.19 |
| Sept. 28, 2026 | $24.00 |
| Sept. 25, 2026 | $25.54 |
| Sept. 24, 2026 | $26.07 |
| Sept. 23, 2026 | $27.88 |
| Sept. 22, 2026 | $28.68 |
| Sept. 21, 2026 | $28.30 |
| Sept. 18, 2026 | $29.29 |
| Sept. 17, 2026 | $30.58 |
| Sept. 16, 2026 | $25.94 |
| Sept. 15, 2026 | $25.50 |
| Sept. 14, 2026 | $26.26 |
| Sept. 11, 2026 | $27.01 |
| Sept. 10, 2026 | $28.44 |
| Sept. 9, 2026 | $29.11 |
| Sept. 8, 2026 | $29.30 |
| Sept. 4, 2026 | $30.21 |
| Sept. 3, 2026 | $28.85 |
| Sept. 2, 2026 | $29.98 |
| Sept. 1, 2026 | $30.98 |
| Aug. 31, 2026 | $32.96 |
| Aug. 28, 2026 | $37.00 |
| Aug. 27, 2026 | $38.00 |
| Aug. 26, 2026 | $39.64 |
| Aug. 25, 2026 | $39.25 |
| Aug. 24, 2026 | $39.50 |
| Aug. 21, 2026 | $36.42 |
| Aug. 20, 2026 | $38.20 |
| Aug. 19, 2026 | $40.60 |
| Aug. 18, 2026 | $41.52 |
| Aug. 17, 2026 | $41.40 |
| Aug. 14, 2026 | $42.49 |
| Aug. 13, 2026 | $42.72 |
| Aug. 12, 2026 | $42.77 |
| Aug. 11, 2026 | $42.94 |
| Aug. 10, 2026 | $41.97 |
| Aug. 7, 2026 | $41.43 |
| Aug. 6, 2026 | $41.64 |
| Aug. 5, 2026 | $37.70 |
| Aug. 4, 2026 | $37.96 |
| Aug. 3, 2026 | $33.59 |
| July 31, 2026 | $35.02 |
| July 30, 2026 | $32.99 |
| July 29, 2026 | $30.45 |
| July 28, 2026 | $28.05 |
Key figures
- Average daily volume
- 100,983Past 3 months
- Market value
- $53.4M
- Dividend yield
- —
Price change
- 1 month
- −21.69%
What Wall Street says about YARW
In the past 90 days, Wall Street firms published 1 rating or price-target action on YARW: 1 new rating.
| Action | Rating | |||
|---|---|---|---|---|
| BTIG | Initiates coverage | Buy | $58 |
Ratings and price targets are the firms’ own opinions, reported as published.
Not investment advice.
About Yarrow Bioscience, Inc. Common Stock
Yarrow Bioscience Inc is a clinical-stage biopharmaceutical company focused on developing biotherapeutics for autoimmune thyroid diseases. Its flagship product candidate, YB-101 (also known as GenSci098), is a humanized, monoclonal antibody targeting the thyroid-stimulating hormone receptor, which Yarrow plans to develop for the treatment of Graves' disease (GD) and potentially thyroid eye disease (TED). The company has one reportable segment relating to the research and development of its research programs, GD and TED.
- Headquarters
- New Haven, Conn.
- Listed
- July 28, 2026
- Sector
- Health care
- Industry
- Pharmaceutical preparations
In WallStreetDigest editions
No WallStreetDigest article about YARW is on the site yet.